BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2725626)

  • 21. Modest dietary restriction and serum somatomedin-C/insulin like growth factor-I in young, mature and old rats.
    Prewitt TE; D'Ercole AJ
    Prog Clin Biol Res; 1989; 287():157-62. PubMed ID: 2922425
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical application of serum somatomedin determination].
    Pertzelan A; Kowadlo-Silbergeld A; Mameat R; Nevo Z; Laron Z
    Harefuah; 1979 May; 96(9):519-21. PubMed ID: 520926
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor.
    Ruggeri BA; Klurfeld DM; Kritchevsky D; Furlanetto RW
    Cancer Res; 1989 Aug; 49(15):4130-4. PubMed ID: 2501021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of insulin-like growth factor assays.
    Lee PD; Rosenfeld RG
    Pediatrician; 1987; 14(3):154-61. PubMed ID: 3331010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatomedin-C is not increased in the serum of patients with amyotrophic lateral sclerosis.
    Denys EH; Pelle-Day G; Spencer EM
    Muscle Nerve; 1988 Sep; 11(9):1000-1. PubMed ID: 3173414
    [No Abstract]   [Full Text] [Related]  

  • 27. Assay of somatomedin C by cartridge extraction prior to radioimmunoassay with antiserum developed against synthetic somatomedin C.
    Kao PC; Tateishi K; Abboud CF; Zimmerman D; Randall RV; Li CH
    Ann Clin Lab Sci; 1988; 18(2):120-30. PubMed ID: 2454603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiological and clinical aspects of the insulin-like growth factors.
    Zapf J; Froesch ER
    Horm Res; 1986; 24(2-3):160-5. PubMed ID: 3530939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls.
    Taylor AM; Dunger DB; Grant DB; Preece MA
    Diabetes Res; 1988 Dec; 9(4):177-81. PubMed ID: 3248365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factors I and II in children with systemic onset juvenile arthritis.
    Bennett AE; Silverman ED; Miller JJ; Hintz RL
    J Rheumatol; 1988 Apr; 15(4):655-8. PubMed ID: 3397975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the levels of growth hormone, insulin, somatomedin C and thyroxine in sheep during immunization against somatostatin.
    Spencer GS; Hallett KG; Fadlalla AM; Spencer EM
    Endocrinol Exp; 1987 Dec; 21(4):299-306. PubMed ID: 2894294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Low levels of somatomedin C and short stature in the Silver-Russell syndrome].
    Di Pietro A; Proverbio MR; D'Avolio G; Coletta M; Tammaro V
    Pediatr Med Chir; 1994; 16(2):153-4. PubMed ID: 8078790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Somatomedins--a review. 2. Age and nutrition dependence, somatomedin concentration in endocrine and non-endocrine diseases].
    Jahreis G; Hesse V
    Kinderarztl Prax; 1983 Sep; 51(9):403-12. PubMed ID: 6656098
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum fibronectin and somatomedin-C as nutritional markers in adults receiving total parenteral nutrition.
    Powers DA; Franse VL; Brown RO; Hinson A; Cowan GS
    Clin Pharm; 1988 Dec; 7(12):889-93. PubMed ID: 3145166
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum insulin-like growth factor I (somatomedin-C) level in normal subjects from infancy to adulthood, pituitary dwarfs and normal variant short children.
    Suwa S; Katsumata N; Maesaka H; Tokuhiro E; Yokoya S
    Endocrinol Jpn; 1988 Dec; 35(6):857-64. PubMed ID: 3250861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low somatomedin C and high growth hormone levels in newborns damaged by maternal alcohol abuse.
    Halmesmäki E; Välimäki M; Karonen SL; Ylikorkala O
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):366-70. PubMed ID: 2761912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunoassay of somatomedin C/insulin-like growth factor I.
    Furlanetto RW; Marino JM
    Methods Enzymol; 1987; 146():216-26. PubMed ID: 3316933
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma somatomedin-C levels in psoriasis.
    Nickoloff BJ; Misra P; Morhenn VB; Hintz RL; Rosenfeld RG
    Br J Dermatol; 1987 Jan; 116(1):15-20. PubMed ID: 3814511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.